Medpace Holdings, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Medpace Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $6.42M, a 1789.41% increase year-over-year.
- Medpace Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $12.67M, a 51.17% decline year-over-year.
- Medpace Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $7.99M, a 27.30% increase year-over-year.
- Medpace Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $340.00K, a 48.95% decline year-over-year.
- Medpace Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $57.00M, a 259.45% increase from fiscal 2024.
- Medpace Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $15.86M, a 39.37% increase from fiscal 2023.
- Medpace Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $11.38M, a 48.46% decline from fiscal 2022.
- Medpace Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $22.07M, a 25.11% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $6.42M 10-Q · filed 2026-07-23 | |
| 2026-03-31 | $12.67M 10-Q · filed 2026-07-23 | |
| 2025-12-31 | $57.00M 10-K · filed 2026-02-10 | |
| 2025-09-30 | $7.99M 10-Q · filed 2025-10-23 | |
| 2025-06-30 | $340.00K 10-Q · filed 2026-07-23 | |
| 2025-03-31 | $25.95M 10-Q · filed 2026-07-23 | |
| 2024-12-31 | $15.86M 10-K · filed 2026-02-10 | |
| 2024-09-30 | $6.27M 10-Q · filed 2025-10-23 | |
| 2024-06-30 | $666.00K 10-Q · filed 2025-10-23 | |
| 2024-03-31 | $7.66M 10-Q · filed 2025-10-23 | |
| 2023-12-31 | $11.38M 10-K · filed 2026-02-10 | |
| 2023-09-30 | $5.70M 10-Q · filed 2024-10-22 | |
| 2023-06-30 | $1.70M 10-Q · filed 2024-10-22 | |
| 2023-03-31 | $2.46M 10-Q · filed 2024-10-22 | |
| 2022-12-31 | $22.07M 10-K · filed 2025-02-11 | |
| 2022-09-30 | $892.00K 10-Q · filed 2023-10-24 | |
| 2022-06-30 | $1.52M 10-Q · filed 2023-10-24 | |
| 2022-03-31 | $13.90M 10-Q · filed 2023-10-24 | |
| 2021-12-31 | $17.64M 10-K · filed 2024-02-13 | |
| 2021-09-30 | $1.00M 10-Q · filed 2022-10-25 | |
| 2021-06-30 | $5.10M 10-Q · filed 2022-10-25 | |
| 2021-03-31 | $9.11M 10-Q · filed 2022-10-25 | |
| 2020-12-31 | $15.99M 10-K · filed 2023-02-14 | |
| 2020-09-30 | $8.24M 10-Q · filed 2021-10-26 | |
| 2020-06-30 | $633.00K 10-Q · filed 2021-10-26 | |
| 2020-03-31 | $1.34M 10-Q · filed 2021-10-26 | |
| 2019-12-31 | $6.47M 10-K · filed 2022-02-15 | |
| 2019-09-30 | $1.79M 10-Q · filed 2020-10-27 | |
| 2019-06-30 | $2.90M 10-Q · filed 2020-10-27 | |
| 2019-03-31 | $934.00K 10-Q · filed 2020-10-27 | |
| 2018-12-31 | $2.54M 10-K · filed 2021-02-16 | |
| 2018-09-30 | $635.00K 10-Q · filed 2019-10-29 | |
| 2018-06-30 | $609.00K 10-Q · filed 2019-10-29 | |
| 2018-03-31 | $566.00K 10-Q · filed 2019-10-29 | |
| 2017-12-31 | $1.81M 10-K · filed 2020-02-25 | |
| 2016-12-31 | $678.00K 10-K · filed 2019-02-26 | |
| 2015-12-31 | $250.00K 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |